Insights Into Prostate Cancer 2025
Perspectives on drivers in treatment decisions in the management of prostate cancer
Puerto Rico – February 17, 2025
Faculty Chair
Jorge A. Garcia, MD, FACP
Case Western Reserve University, Cleveland, OH, USA
Southeast – March 22, 2025
Faculty Chair
Jacqueline Brown, MD
Winship Cancer Institute, Atlanta, GA, USA
West – March 27, 2025
Faculty Chair
Helen Moon, MD
Kaiser Permanente, Riverside, CA, USA
Central – April 4, 2025
Faculty Chair
Russell Szmulewitz, MD
University of Chicago Medical Center, Chicago, IL, USA
Southwest – May 3, 2025
Faculty Chair
Alan Bryce, MD
City of Hope Cancer Center, Phoenix, AZ, USA
East – June 16, 2025
Faculty Chair
Charles Ryan, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
More Information
- Virtual series
- Puerto Rico
More Information
- Atlanta, GA
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Virtual
More Information
- Dallas, TX
- Arkansas, Kansas, Louisiana, Missouri, Oklahoma, Texas
More Information
- Phoenix, AZ
- Arizona, Colorado, Nevada, New Mexico, Southern California, Utah
More Information
- Virtual
REPORT SNAPSHOT
- A moderated roundtable discussion focusing on the treatment of prostate cancer
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: apalutamide, darolutamide, enzalutamide, androgen deprivation therapy, docetaxel, abiraterone, and combinations of these drugs
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region
